KIAA1549 and low grade glioma: Additionally, it proved efficacy in recurrent pediatric low-grade glioma.38–40 A combinatorial approach was administered in a patient with diffuse leptpomeningeal glioneuronal tumor and KIAA1549-BRAF fusion who shows durable response over more than 11 months.